Transfusion

Article	Citations
Relationship between B‐cell epitope structural properties and the immunogenicity of blood group antigens: Outlier properties of the Kell K1 antigen	70
Transfusion‐associated adverse events incidence and severity after the implementation of an active hemovigilance program with 24 h follow‐up. A prospective cohort study	58
A monthly roundup of key articles in other journals	57
Continuing Medical Education Program in Transfusion	50
Current advances in transfusion medicine 2021: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee	44
Platelet refractoriness associated with platelets stored in platelet additive solution	42
Reducing unnecessary premedication prior to parenteral iron therapy: A quality improvement project	35
Patient ABO blood type is a major predictor of a positive DAT following a transfusion reaction	31
Sickle cell trait results in a high leukoreduction quality control failure rate for whole blood donations	30
A data‐driven approach to determine daily platelet order quantities at hospitals	28
Allo‐anti‐M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion	28
Engaging blood donors as advocates: Social media preferences and associations with marketing stimuli	27
Noninvasive screening of fetal RHD genotype in Chinese pregnant women with serologic RhD‐negative phenotype	27
Assessing HIV trends among blood donors in five Brazilian blood centers: The impact of individual donor assessment	27
Transfusion‐associated hyperkalemia in pediatric population: Analyses for risk factors and recommendations	27
Who donates? Patterns of blood donation and donor characteristics at a university‐affiliated hospital‐based donor center	26
Clinical grade production of IL‐15 stimulated NK cells for early infusion in adult AML patients undergoing haploidentical stem cell transplantation with post‐transplan	26
Identification of a novel B allele with a c.256G>A mutation on the ABO*B.01 allele	25
Elevated INR in the ICU and plasma transfusion	25
Prenatal management of fetal anemia due to pyruvate kinase deficiency: A case report	25
Continuing Medical Education	23
Platelet membrane‐derived microparticles may be biomarkers in patients with hepatocellular carcinoma and can promote the invasion and metastasis of hepatoma carcinoma cells	22
Identification of a novel A allele with c.478C>T missense mutation on the ABO*A1.02 background	21
Antigen‐specific IgG subclass composition in recipient mice can indicate the degree of red blood cell alloimmunization as well as discern between primary and secondary immunization	21
2022 Plenary, Oral, and Poster Abstract Presentations	21

A novel RHCE*Ce710A allele (p.237Asp) in a Japanese patient with weak expression of C and no detectable e	21
Author Index	21
	21
Abstract Awards	20
Disentangling the causes of RBC loss and anemia in ECMO patients: Some questions answered?	19
Identification of a novel A allele with a c.977A>C variation on the ABO*A1.02 allele	19
Effect of special operational forces surgical resuscitation teams on combat casualty survival: A narrative review	18
Multiorgan failure in a fatal case of autoimmune hemolytic anemia	18
Masthead and Table of Contents	18
Efficacy and safety of turoctocog alfa in patients with hemophilia A requiring surgical procedures: A multicentre retrospective study	17
Optimizing electronic blood ordering and supporting administration workflows to improve blood utilization in the pediatric hospital setting	17
Recognizing the microgranular variant of acute promyelocytic leukemia when considering leukapheresis	16
Therapeutic plasma exchange for the treatment of extracorporeal membrane oxygenation dysfunction caused by hypertriglyceridemia	16
Evaluation of an improved rapid bacterial assay with untreated and pathogen‐reduced platelets: Detection of Acinetobacter strains	16
A new missense variant c.278C > G on the ABO*B.01 allele associated with a Bel phenotype	16
Patient perspectives on intraoperative blood transfusion: A qualitative interview study with perioperative patients	16
Continuing Medical Education	16
Cover	16
A monthly roundup of key articles in other journals	16
How do we perform intrauterine transfusions?	16
Collection efficiency and safety of large‐volume leukapheresis for the manufacturing of tisagenlecleucel	15
Leukoreduction as a control measure in transfusion transmission of visceral leishmaniasis	15
Red blood cell alloimmunization in patients on extracorporeal membrane oxygenation	15
The 2023 AABB international guidelines for red blood cell transfusions: What is new?	15
Identification of a novel O allele with c.777C>G on an ABO*O.01.02 background	15
Gross lipemia and blood bank testing	15
Identification of a novel A4GALT*299A allele associated with the rare p phenotype in one Chinese family	15
Sickle cell disease and the need for blood: Barriers to donation for African, Caribbean, and Black young adults in Canada	15
Red blood cell reduction of a sickle cell disease stem cell product	14
Survey of the RhD selection and issuing practices for uncrossmatched blood products at pediatric trauma hospitals in the United States: The BEST collaborative study	14
Five novel silenced KEL*02 alleles	14
How do I transfer liquid nitrogen freezers to a new home safely?	14
How did we reform our out of control massive transfusion protocol program?	14
Subject Index	14
Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks	14
Masthead and Table of Contents	13
A novel KEL null allele with c.223+1g>t leads to the absence of the Kpb antigen in a First Nation donor	13
Protamine dosing and its impact in cardiac surgery transfusion practice—A retrospective bi‐institutional analysis	13
The platelet proteasome and immunoproteasome are stable in buffy‐coat derived platelet concentrates for up to 7 days	13
Continuing Medical Education Program in Transfusion	13
Neutralization profile of SARS‐CoV‐2 omicron BA.1 variant in high binding titer plasma	13
A monthly roundup of key articles in other journals	13
We stand ready … Blood collection organizations and the COVID‐19 pandemic	13
Optimizing damage control resuscitation through early patient identification and real‐time performance improvement	12
X‐ and gamma‐irradiation have similar effects on the in vitro quality of stored red cell components	12
Identification of a novel FUT1 allele in a Chinese individual with para‐Bombay phenotype	12
Continuing Medical Education	12
Blood consumption in the Role 2 setting: A Department of Defense Trauma Registry analysis	12
Whole blood derived and apheresis platelets: Opinions and preferences—the results of a national survey of blood collectors	12
Demographic, clinical, and biochemical predictors of pica in a large cohort of blood donors	12

Masthead and Table of Contents	12
	12
How we secured a COVID‐19 convalescent plasma procurement scheme in Japan	12
Measurement of post‐transfusion red blood cell survival kinetics in sickle cell disease and β‐Thalassemia: A biotin label approach	12
Regulatory T cells: A review of manufacturing and clinical utility	12
A variant allele with c.467C>T and c.784G>A is not a novel allele but ABO*AW10	12
Reported transfusion‐related acute lung injury associated with solvent/detergent plasma – A case series	12
Glucose‐6‐phosphate dehydrogenase deficiency is more prevalent in Duffy‐null red blood cell transfusion in sickle cell disease	11
The senescent antigen hypothesis of RBC evanescence: 50 years of correlation without causation	11
Evaluation of KP‐1199: a novel acetaminophen analog for hemostatic function and antinociceptive effects	11
P‐IG‐43 | Targeted Sequencing Resolves ABO Discrepancy in a Patient with Rare ABO Genotype	11
Hereditary thrombocytopenia with platelet sialic acid deficiency and mutations in the GNE genes	11
Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease	11
Table of Contents	11
Cover	11
Masthead	11
The timing of gamma irradiation and its effect on cell‐free and microvesicle‐bound hemoglobin. The BEST collaborative study	11
A whole blood based resuscitation strategy in civilian medical services: Experience from a Norwegian hospital in the period 2017–2020	11
Powassan virus: What is the risk to the blood supply?	11
Anti‐Kg antibodies induce monocyte phagocytosis of the red blood cells	11
P‐TS‐91 | Transfusion of Red Cells in Pediatric Patients During ECMO Runs: A Single Center Audit	10
P‐BB‐47 | Improving Blood Availability in Blood Deserts of LMICs through Implementation of Civilian Walking Blood Banks: Conclusions from an International Working Group	10
P‐BB‐53 | Is Average Donor Platelet Count Equivalent to Manufacturer's Recommended Average?	10
P‐BB‐21 | Choosing the Best Source of WBCs: Apheresis LRS Chambers versus Buffy Coat Products	10
P‐IG‐24 | Immune‐Mediated Platelet Transfusion Refractoriness Complicated by Panagglutinin and Prozone Effect: A Case Report	10
P‐PB‐14 | Patient Blood Management (PBM): Interactive Transfusion Dashboard in a Healthcare System	10
Subject Index	10
P‐TS‐25 | Developing a Tool to Assess Red Blood Cell Clearance in Vivo Utilizing Pathogen‐Reduced RBCs	10
P‐TS‐47 | Improving the Frequency of Post‐Transfusion Platelet Counts with Unit Tags	10
P‐BB‐22 | CLIA‐Waived Hematology Analyzer Quandary: What to With **** Results in Platelet Donor Qualification	10
P‐BB‐34 | Establishing a Platelet Apheresis Unit in Zambia a Resource Restricted Country	10
P‐IT‐5 | Development and Implementation of a Novel Transfusion Medicine Dashboard	10
P‐BB‐35 | Evaluating Thrombocytosis in Apheresis Platelet Donors	10
P‐CB‐2 | Amotosalen/UVA Treatment of Platelet and Plasma Components using the INTERCEPT Blood Systems to Inactivate WHO Reference Bacterial Strains	10
P‐IG‐41 | Sickle Trait Prevalence Among the RBC Units Used in a Pediatric Hospital in Costa Rica Between May and October 2019	10
OA3‐AM23‐MN‐13 | Morphologically altered Red Blood Cells that Accumulate During Storage Have Altered Proteostasis and Post‐transfusion Spleen Retention	9
Masthead	9
OA3‐AM23‐ST‐24 | In Vitro Evaluation of Whole Blood Componentized with an Automated Blood Processing System and Stored in a Non‐DEHP Plasticized Bag System	9
P‐BT‐1 | What to Expect When You Request Post‐Thaw Segment QC Testing on a Cord Blood Unit?	9
P‐IG‐27 | Investigation of Four Patient Samples with Weak D Typing Revealed Four Novel RHD Alleles	9
P‐TS‐28 | Effect of Cryopreserved Platelets on Blood Loss and Platelet Count Increment Compared with Standard Platelet Transfusion: A Systematic Review	9
P‐TS‐19 | Comparison of Platelet Increment with Conventional Versus Psoralen‐treated Platelets Suspended in Platelet Additive Solution or Plasma	9
P‐IG‐45 | The RHAG*01N.26 Variant Does Not Lead to Rh‐Null but to Rh‐Mod Phenotype: The Importance of Absorption and Elusion Assays	9
P‐BB‐52 | Interim Platelet Units Prepared from Automated WB Processing Meet In Vitro Acceptance Criteria and are Less Activated than Manually Prepared PRP Platelets	9
P‐IG‐46 | Weak and Partial D Genotype Frequencies in a Large Integrated Healthcare Delivery System in the USA	9
P‐TS‐18 | Collecting a Pre‐Operative Type and Screen Anywhere in the System	9
P‐BT‐16 | Low Mechanical Stress and High Throughput Concentration of Cells with Acoustophoresis	9
OA2‐AM23‐MN‐13 | Metabolite Levels from End of Storage Red Blood Cells are Reproducible Within the Same Donor Across Multiple Donations	9
OA2‐AM23‐SN‐18 | Do Doctors Dream of Electric Blood Bankers? Publicly Available Artificial Intelligence Chatbots Make Transfusion Decisions with Accuracy and Precision	9
P‐TS‐1 | A Case of a Possible Transfusion‐Associated Fatality: The Continued Challenges of Managing and Treating Patients in Sickle Cell Crisis	9
P‐TS‐33 | Following the Disposition of Low‐Titer Group O Whole Blood at a Level 1 Trauma Center	9
P‐TS‐22 | Cryoprecipitate Usage, Policy, and Practices Among Blood Banks in the United States	9
P‐IT‐13 | Use of Pulse Oximeter and Pulse Rate Time‐Series Processing to Understand Physiologic Changes Associated with Transfusion in Very Preterm Infants	9
P‐TS‐77 | Safety and Utility of an Approach in the Management of Patients with RBC Alloimmunization Undergoing Liver Transplantation	9
P‐BB‐14 | Analysis of the Benefit of Implementing a Helipad for Rotation and Resupply of Low‐Titer O Whole Blood to Prehospital Entities	9
P‐CB‐6 | Composition of Platelet Additive Solution Impacts Bioenergetic Status of Platelets Following Cold Storage: Role of pH and Fuel Substrates	9
P‐TS‐11 | An Unusual Case of Transfusion Related Acute Lung Injury	9
P‐BT‐13 | Hematology Analyzer Evaluation for Cellular Therapies	9
P‐CB‐18 | Modified Platelet Storage Devices to Improve Quality During Storage	9
P‐TS‐45 | Improving Blood Transfusion Ordering for Patients with Sickle Cell Disease	9
P‐TS‐49 | INTERCEPT Treatment of Contaminant Bacteria Enterobacter soli, Leclercia adecarboxylata, and Staphylococcus saprophyticus in Human Apheresis Platelets	9
P‐IG‐34 | Novel FUT1 Variant c.789C>A in Patient with Para‐Bombay Phenotype and Evaluation by Protein Modeling	9
P‐MG‐3 | Workload Triage During Critical Staffing Levels	8
P‐ED‐6 | Transfusion Medicine: Continuing Education via Digital Programming	8
P‐BB‐24 | Comparing Cryoprecipitate Fibrinogen Content by Plasma Thawing Technique	8
P‐TS‐84 | The Incidence of Reported Transfusion Related Acute Lung Injury (TRALI) by Blood Component: A Systematic Review and Meta‐Analysis	8
P‐BT‐28 | Values of CD34+ and Total Nucleated Cells in Human Cord Blood Products in a Specific Ethnic Group of Hispanics	8
P‐CB‐8 | Distinct Inflammatory Signals Can Enhance or Reduce Alloantibody Responses to Primary Platelet Transfusion and Alter Recall Responses in Mice	8
Continuing Medical Education	8
Duties to donors	8
Comparison of CD34+ cell mobilization, blood graft cellular composition, and post‐transplant outcome in myeloma patients mobilized with filgrastim or pegfilgrastim added to low‐d	8
P‐PH‐1 | Early Experience of Recruiting Donors into a Large Cohort Study and Biobank	8
P‐TS‐43 | Improved Operational Efficiency With Pathogen Reduced Cryoprecipitated Fibrinogen Complex Versus CryoAHF	8
P‐BB‐72 | Survival of Plasmodium Falciparum Parasites in Human Plasma Under Different Storage Temperatures	8
P‐TS‐68 | Presence of Isohemagglutinins in Group O Neonates: Potential Implications for ABO Incompatible Heart Transplants	8
P‐BB‐63 | Preliminary Feasibility of an Artificial Intelligence (AI) Smartphone‐Based ABO‐RhD Blood Typing Kit to Reach New Blood Donors	8
P‐PB‐4 | Adding Another Layer of Safety: Should the Blood Bank ‘Baby‐Sit’ Blood Orders for Patients Scheduled for Surgery?	8
P‐BB‐25 | Comparison of Cryoprecipitated AHF Manufactured from FFP and PF24	8
Trend of blood donors entering the coronavirus pandemic era and challenges: Age‐period‐cohort analysis using 75.5 million all blood donations data during 2006–2020 in Japan	8
Identification of a novel KLF1 gene promoter variation (c.–251C > G) in a Thai blood donor with In(Lu) phenotype	8

Identification of a novel weak A allele with c.27delC in a Chinese individual	8
OA4‐AM23‐SN‐19 | Transfusion‐Transmitted Babesiosis Reported to Food and Drug Administration Before and after Implementation of the Final Guidance, 2017–2022	8
P‐BB‐23 | Clinical and Epidemiological Characteristics of Arbovirus Infections in Blood Donors	8
P‐BB‐55 | Lower Cost of Monitoring Leukocyte Reduction QC of Platelets with No Sampling	8
OA1‐AM23‐SN‐18 | “Are my blood products coming?” A Novel Blood Tracker in Our Electronic Medical Record	8
P‐IG‐18 | Donor with McLeod Phenotype Carries XK Allele with Nonsense Variant c.664C>T (p.R222X)	8
P‐IG‐4 | Soluble A Antigen Confounding Blood Type in an ABO Mismatched Stem Cell Transplant Patient: A Case Report	8
Table of Contents	8
P‐IG‐15 | Comparison of Conventional Tube Test and a Novel Gel Method to Detect C3d in the Direct Antiglobulin Test	8
P‐BB‐44 | Impact of Label Orientation on In Vitro Parameters of Platelets During Storage	8
Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility study	8
In response: Approaching risk assessment with caution: Epsilon aminocaproic acid and acute kidney injury in the secondary analysis	8
Hematopoietic progenitor cell count as a potential quantitative marker in apheresis products during allogeneic stem cell transplantation	8
OA3‐AM23‐SN‐18 | Routine RBC Reduction of Bone Marrow Products Before Cryopreservation Results in Acceptable Cell Recovery and Viability and does not Affect Engraftment	8
Immune globulin usage trends in commercially insured and Medicare populations, 2009–2019	8
P‐QU‐4 | Impact of Enhancing Criteria for Recognition of Transfusion Reactions	8
The publication impact of the first 100 THOR Network publications by bibliometric and social network analyses	7
How do we leverage data through replication and warehousing to meet blood collection and transfusion service needs	7
A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system	7
Unexpected difficulty in performance of a monocyte monolayer assay when using RBCs from a patient with sickle cell disease	7
Silvernanoparticle‐induced hemolysis confounded with direct antiglobulin test‐negative autoimmune hemolytic anemias diagnosis	7
Cover	7
Bacterial agents (3rd section)	7
Masthead and Table of Contents	7
Identification of a novel a variant at the ABO locus in Chinese Han individuals with a A2 phenotype	7
	7
Blood safety markers in Dutch donors after relaxation of deferral for men who have sex with men: re‐emergence of syphilis and HIV pre‐exposure prophylaxis use	7
The first two years of the use of low titer group O whole blood during French Military overseas operations: A retrospective study	7
Compensatory reserve and pulse character: Enhanced potential to predict urgency for transfusion and other life‐saving interventions after traumatic injury	7
In memoriam: Dr. Dirk de Korte	7
Effects of donation frequency on U.S. source plasma donor health	7
How platelet transfusions were invented	7
Homozygous SPTA1‐associated hereditary pyropoikilocytosis presenting as hydrops fetalis	7
Evaluating apheresis platelets at reduced dose as a contingency measure for extreme shortages	7
Other bacterial agents (4th section)	7
Hemostatics in patients with inhibited coagulation—A viscoelastic in‐vitro analysis	7
Critical failure of a cell therapy products storage tank: Description, investigation and implemented improvements	7
Evaluation of platelets componentized with the Reveos Automated Blood Processing System and stored for 7 days at room temperature in a non‐Di(2‐ethylhexyl) phthalate (DEHP) platelet pooling set	7
Impact of systematic variations in hematocrit and platelet count on thrombelastometry tissue factor activated assay parameters	7
Association between clinical symptoms during the COVID‐19 infection and SARS‐CoV‐2 immunoglobulin G titers in COVID‐19 convalescent whole‐blood donors in Ch	7
A lower fibrinogen threshold does not lead to increased bleeding risk in patients receiving therapeutic plasma exchange: A prospective single‐center analysis	7
Identification of two novel FUT1 alleles in a Chinese para‐Bombay individual	7
Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial	7
Vesiculation in irradiated and cation‐leaky‐stored red blood cells	7
How do we design a laboratory space for a hospital transfusion medicine service?	7
Hepatitis E virus is effectively inactivated by methylene blue plus light treatment	7
Paid platelet donors: Points to consider	7
Massive amorphous mass in apheresis platelet product	7
Effect of major trauma on the expected number of births in Finnish women: A nationwide population‐based public data and register analysis	7
How do I think about blood donor eligibility criteria for medical conditions?	7
A pilot study of the metabolic profiles of apheresis platelets modified by donor age and sex and in vitro short‐term incubation with sex hormones	6
Standardized reporting of pulmonary transfusion complications: Development of a model reporting form and flowchart	6
A monthly roundup of key articles in other journals	6
Plasma exchange using peripheral arterial and venous access in the pediatric intensive care unit	6
OA4‐AM23‐MN‐36 | Modulation of Neutrophil Function by Red Cell Exchange in Patients with Sickle Cell Disease	6
Dissociation of IgM antibodies from red blood cells using ethylenediamine tetraacetate/glycine acid or chloroquine diphosphate	6
D−− phenotype caused by a novel RHCE null allele	6
Masthead and Table of Contents	6
COVID‐19 vaccine humoral response in frequent platelet donors with plateletpheresis‐associated lymphopenia	6
Antibodies against biotin‐labeled red blood cells can shorten posttransfusion survival	6
Administration of blood products in the prehospital setting can decrease trauma patient mortality	6
Identification of a novel RHAG allele with a c.500A>G variation associated with Rhmod phenotype	6
	6
Monocyte monolayer assay predictions of clinical outcome for serologically incompatible red blood cells is all about timing	6
Donor variation in stored platelets: Higher metabolic rates of platelets are associated with mean platelet volume, activation and donor health	6
Table of Contents	6
Leading digit bias in hemoglobin thresholds for red cell transfusion	6
Identification of a novel FUT1 allele with c.325_414dup in a Chinese individual with para‐Bombay phenotype	6
Effects of radiation exposure and storage on the energy metabolome of platelets in whole blood	6
The impact of institutional measures on optimal use of intravenous immunoglobulin	6
Hyperbaric treatment of platelets extends in vitro storage to 14 days	6
An adaptive platform trial for evaluating treatments in patients with life‐threatening hemorrhage from traumatic injuries: Planning and execution	6
Risk factors for vasovagal reactions in blood donors: A systematic review and meta‐analysis	6
A monthly roundup of key articles in other journals	6
The use of low‐titer group O whole blood is independently associated with improved survival compared to component therapy in adults with severe traumatic hemorrhage	6
Molecular and serological analysis of the D variant in the Chinese population and identification of seven novel RHD alleles	6
Biochemical characterization of Jr(a−) blood type‐related ABCG2 variants: Arg147Trp and Ser572Arg disrupt the plasma membrane localization of ABCG2	6
A monthly roundup of key articles in other journals	6
Irradiated red blood cells: Can all sins be washed away?	6
Massive transfusion protocol reactivation as a novel marker of physician team under‐triage after injury	6
Two novel platelet biotinylation methods and their impact on stored platelet concentrates in a blood bank environment	6
Fever accompanied by basophil activation in response to transfused blood products in an adult patient	6
New RHCE*CE(c.382G > a) allele in patients of Asian ancestry	6
Cover	6
Comparative efficacy of liberal and restrictive blood transfusion strategies in anemic patients with acute myocardial infarction: A systematic review and meta‐analysis of randomized controlled trials	6
Climate change and parasitic risk to the blood supply	6
Hemoglobin‐based oxygen carriers: Biochemical, biophysical differences, and safety	6
A report on a modified protocol for flow cytometry‐based assessment of blood group erythrocyte antigens potentially suitable for analysis of weak ABO subgroups	6
Further thoughts on a lower fibrinogen threshold prior to therapeutic plasma exchange	6
Estimating the impact on the inventory of implementing pathogen‐reduced platelets in Canada	6
Effective peripheral blood stem cell collection in a 4.6‐kg child	6
Healthcare center‐based cell therapy laboratories supporting off‐site manufactured cell therapies: The experiences of a single academic cell therapy laboratory	6
A novel RHD allele caused by c.767 C>T mutation was identified in a Chinese individual	6
In response: ABO nonidentical platelet transfusions and mortality	6
Stem‐cell mobilization of healthy sibling donors with pegfilgrastim—A prospective open‐label phase II trial (EudraCT no: 2005‐004971‐39)	6